top of page

HTA, REIMBURSEMENT & PRICING

​​

We deliver streamlined solutions to enable patients faster access to innovative medicines​

REAL WORLD EVIDENCE

HEALTH ECONOMICS

EVIDENCE GENERATION

ACCESS STRATEGY

​

​

Transforming global vision into local execution.

HEALTH ECONOMICS AND OUTCOMES RESEARCH

WHY EVIMED ?

​

​

As strategic allies, we combine deep industry knowledge with first-hand experience of developing and defending reimbursement dossiers. We deliver fit-for-purpose evidence that anticipates decision-maker questions and supports better access decisions.

Your strategic ally

​​​
We have been on the other side of the submission​.

​
 

AGENCIES

Expert-led projects

Senior consultants with proven track records lead every engagement, ensuring strategic oversight and accountability throughout your project lifecycle.

Technical and therapeutic depth

Advanced analytical capability combined with therapeutic area depth, meeting the standards of regulatory and HTA bodies.

Global and local knowledge

Expertise spanning 40+ markets, translating global strategy into locally relevant solutions that address country-specific HTA requirements.

Strategically alligned

We align your evidence generation strategy with future access requirements, addressing payer needs before they become obstacles.

WHAT WE DO

01

Literature Review and Evidence Synthesis

​​

​

Evidence That Accelerates Access.

​​

​

From Data to Decisions - Fast.

Submission-ready deliverables in less time.

02

Health Economic Modelling

​

Models Built for Impact.

​​

Modelling global and local needs for pricing, reimbursement, and strategic decision-making.

​

03

Statistical Data Analysis

​

Analytics Driven By Strategy

​

Technical rigor meets strategic thinking to deliver analysis that supports your access objectives.

​

04

Health Technology Assessment

​

Global Vision. Local Execution.

​

Delivering outcomes from early development to post-launch. We helped shape or deliver over 300 HTA & reimbursement submissions.

​

CLIENT PERSPECTIVES

"Evimed combines scientific rigor with strategic agility. Their collaborative style and ability to tailor insights to real-world decision-making make them a valuable partner in high-stakes access."

Senior Director,

Global Health Outcomes,

Pharma

Let's talk about your access challenge


Tell us the indication, the markets and the deadline. A senior consultant replies — there is no account manager in between.
 

Thanks for submitting!

bottom of page